Home » Newsletters » BioWorld Science

BioWorld Science

July 17, 2007

View Archived Issues

Outcome of Erbitux phase III study in first-line treatment of advanced lung cancer

Ariad and Merck & Co. enter global collaboration to jointly develop and market AP-23573

New therapeutic agents for psychiatric disorders reported in recent patents

Recent patents disclose novel treatments for inflammatory disorders

Patient enrollment begins for phase II IMC-A12 study in advanced colorectal cancer

Encysive Pharmaceuticals provides update on Thelin NDA

Tikvah Therapeutics completes private financing

LAB International changes name to Akela Pharma

Enrollment of phase IIa trial of MEM-3454 for AD completed

Enrollment of Dynavax's pivotal phase III trial of HBV vaccine completed

FDA accepts Collegium's IND for abuse deterrent, sustained release opioid

Jerini Ophthalmic's IND for JSM-6427 for AMD accepted by FDA

Valopicitabine program placed on hold in U.S.

Recent patents impart novel analgesic agents

New Alzheimer's disease remedy disclosed in recent Roche patent

ERCC1 mRNA measurement used to assign non-small cell lung cancer treatment

Clinical centers now being recruited for DIMOND study

RON receptor tyrosine kinase a potential pancreatic cancer target

Renal impairment implicated in progression to prediabetes

Selenium supplementation does not prevent type 2 diabetes

Diabetes incidence reduced in rheumatoid arthritis patients taking hydroxychloroquine

Bionomics advances development of potassium channel Kv1.3 blockers

Studies characterize direct thrombin inhibitor AZD-0837

Colostrinin launched in Australasia

Ceftobiprole filed in Canada for cSSSI

Neupro launched in U.S.

Testosterone MD-Lotion elevates testosterone levels into normal healthy range

Iclaprim achieves primary efficacy endpoint in phase III cSSSI trial

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 12, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...